ELDN (Eledon Pharmaceuticals, Inc.) Stock Market Reviews

crown

search

Read and share opinions on ELDN (Eledon Pharmaceuticals, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock ma

ELDN

Eledon Pharmaceuticals, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Eledon Pharmaceuticals Announces Pricing of $50 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
Nov 12, 2025
Eledon Pharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
Nov 11, 2025
Assessing Eledon Pharmaceuticals (ELDN) Valuation After Phase 2 Kidney Transplant Trial Results and Phase 3 Prospects
Nov 10, 2025
Eledon Pharmaceuticals to Present at Guggenheim Second Annual Healthcare Innovation Conference
Nov 5, 2025
Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 Annual Meeting
Oct 17, 2025
Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association
Sep 24, 2025
Eledon Pharmaceuticals to Participate in Cantor Global Healthcare Conference 2025
Aug 29, 2025
Eledon Pharmaceuticals Reports Second Quarter 2025 Operating and Financial Results
Aug 14, 2025
Eledon Pharmaceuticals to Present Updated Clinical Data for Tegoprubart at World Transplant Congress
Aug 1, 2025
Eledon Pharmaceuticals to Host a Conference Call to Discuss Updated Data from the Ongoing Phase 1b Trial of Tegoprubart in Kidney Transplantation Being Presented at the World Transplant Congress 2025
Jul 30, 2025
Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025
Jul 17, 2025
Best Momentum Stocks to Buy for July 14th
Jul 14, 2025
Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes
Jul 9, 2025
Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City
Jun 25, 2025

Reviews